← All stocks

ALX ONCOLOGY HOLDINGS INC

ALXO Net selling
CIK 0001810182 #3671 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$5.41K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$5.41K
2 of 2 sales
Net
−$5.41K
−$5.41K against sales at will

By person

6 insiders · 2 transactions
0.7×

Jason Lettmann holds only 0.7 times base salary in stock. $568.15K of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason Lettmann last reported holding, valued at $1.93, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Lettmann Jason
CHIEF EXECUTIVE OFFICER
$4.30K (1)
−$4.30K
294,379
$568.15K
+62.3%
Wong Shelly
SVP, FINANCE AND CAO
$1.11K (1)
−$1.11K
87,828
$169.51K
−12.7%
GOODMAN COREY S
Director
8,453,038
$16.31M
+60.5%
Pons Jaume
PRESIDENT & CSO
579,388
$1.12M
−2.0%
Shantharam Harish
Chief Financial Officer
75,000
$144.75K
Hemrajani Rekha
Director
33,000
$63.69K
+1,000%

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 52,743,104 to 138,276,997 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 0
History held since 17 Jul 2020